SCHEMBL26134852

SCHEMBL26134852

Cc1sc(-c2ccc(O)c(O)c2)nc1-c1ccc(F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATP4A P20648 2/20 0.50
▸ ATP4B P51164 2/20 0.50
▸ SNCA P37840 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ RARA P10276 2/20 0.46
▸ RARB P10826 2/20 0.46
▸ RARG P13631 2/20 0.46
▸ APEX1 P27695 1/20 0.45
▸ PLTP P55058 1/20 0.44
▸ APP P05067 3/20 0.43
▸ PTGDR2 Q9Y5Y4 2/20 0.43
▸ MAPT P10636 2/20 0.42
▸ SULT1A1 P50225 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ ESR2 Q92731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26134361 0.88 ATP4A (0.52) ATP4AATP4BSNCAALDH1A1PKM
SCHEMBL26136461 0.87 RARA (0.61) ATP4AATP4BSNCAALDH1A1PKM
SCHEMBL31677663 0.78 ALOX5 (0.56) ATP4AATP4BSNCARARARARB
SCHEMBL9629483 0.73 ALOX5 (0.58) ALDH1A1MAPTKDM4EGAA
SCHEMBL8188473 0.72 ALDH1A1 (0.61) ALDH1A1PKMRARARARBRARG
SCHEMBL4809936 0.72 AHR (0.60) SNCAALDH1A1APPMAPTSULT1A1
SCHEMBL9572144 0.71 ALDH1A1 (0.51) ALDH1A1PKMRARARARBRARG
SCHEMBL26125672 0.70 ALOX5 (0.50) SNCAALDH1A1PKMPTGDR2MAPT
SCHEMBL26135039 0.70 KDM4E (0.68) ATP4AATP4BALDH1A1PKMMAPT
SCHEMBL131267 0.69 SMN1; SMN2 (0.65) ALDH1A1PKMMAPTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME ARKANSAS STATE UNIV JONESBORO (US) 2025-08-28 — — US claimed
WO-2023192595-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME Arkansas State University - Jonesboro (US) 2023-10-05 — — WO claimed
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME ARKANSAS STATE UNIV JONESBORO (US) 2025-08-28 — — US disclosed
WO-2023192595-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME Arkansas State University - Jonesboro (US) 2023-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME TST, GOT2, TPMT ATP4A 2515/4885ATP4B 3496/4885SNCA 4758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback